Author's acknowledgements |
|
ix | |
Publisher's acknowledgements |
|
x | |
Preface |
|
xi | |
Introduction |
|
1 | (2) |
|
1 The professional role of the nurse |
|
|
3 | (20) |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
The Nursing and Midwifery Council |
|
|
6 | (2) |
|
Professional accountability |
|
|
8 | (3) |
|
Why is registration with the NMC necessary? |
|
|
10 | (1) |
|
|
11 | (5) |
|
|
14 | (1) |
|
Breach of that duty of care |
|
|
14 | (1) |
|
|
14 | (2) |
|
Understanding your limitations |
|
|
16 | (1) |
|
|
17 | (2) |
|
|
19 | (1) |
|
So what have you learned? |
|
|
19 | (4) |
|
|
20 | (1) |
|
|
21 | (1) |
|
|
21 | (2) |
|
2 The inter-professional team |
|
|
23 | (20) |
|
|
24 | (1) |
|
|
25 | (1) |
|
Who's who in the inter-professional team |
|
|
26 | (2) |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
The importance of teamwork |
|
|
28 | (3) |
|
What makes a team effective? |
|
|
28 | (3) |
|
|
31 | (6) |
|
Safe medicines management |
|
|
34 | (1) |
|
|
35 | (2) |
|
|
37 | (1) |
|
|
38 | (1) |
|
So what have you learned? |
|
|
39 | (4) |
|
|
40 | (1) |
|
|
40 | (2) |
|
|
42 | (1) |
|
|
43 | (18) |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
45 | (1) |
|
|
46 | (1) |
|
Key organisations and government bodies |
|
|
47 | (2) |
|
|
47 | (1) |
|
Medicines and Healthcare Products Regulatory Agency (MHRA) |
|
|
47 | (1) |
|
National Institute for Health and Clinical Excellence (NICE) |
|
|
48 | (1) |
|
National Patient Safety Agency (NPSA) |
|
|
48 | (1) |
|
Nursing and Midwifery Council (NMC) |
|
|
48 | (1) |
|
Key documents on medicines management |
|
|
49 | (1) |
|
A systems approach to safe medication |
|
|
50 | (2) |
|
Key legislation on medicines and drugs |
|
|
52 | (4) |
|
|
56 | (1) |
|
So what have you learned? |
|
|
57 | (4) |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
60 | (1) |
|
4 Errors in medicines management and their prevention |
|
|
61 | (28) |
|
|
62 | (1) |
|
|
63 | (1) |
|
Mistakes - what are they and why do they happen? |
|
|
63 | (2) |
|
|
64 | (1) |
|
|
64 | (1) |
|
|
65 | (6) |
|
|
65 | (1) |
|
Patient identification errors |
|
|
65 | (2) |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
69 | (2) |
|
Children are potentially more vulnerable |
|
|
71 | (1) |
|
|
72 | (7) |
|
|
79 | (1) |
|
|
79 | (2) |
|
|
79 | (1) |
|
|
80 | (1) |
|
Other measures for error prevention |
|
|
81 | (2) |
|
|
83 | (1) |
|
So what have you learned? |
|
|
84 | (5) |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
87 | (2) |
|
5 Improving knowledge and safety: pharmacological principles |
|
|
89 | (40) |
|
|
90 | (1) |
|
|
91 | (1) |
|
Pharmacological principles |
|
|
92 | (1) |
|
|
92 | (2) |
|
|
94 | (3) |
|
|
97 | (1) |
|
|
98 | (2) |
|
|
100 | (2) |
|
|
102 | (4) |
|
|
102 | (2) |
|
|
104 | (1) |
|
Dosage, formulation and route |
|
|
104 | (1) |
|
Side effects and adverse events |
|
|
105 | (1) |
|
Safe practice and the prevention of errors |
|
|
106 | (1) |
|
Routes of medicine administration |
|
|
107 | (17) |
|
|
108 | (1) |
|
Sublingual and buccal routes |
|
|
109 | (1) |
|
|
109 | (2) |
|
|
111 | (2) |
|
|
113 | (10) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
124 | (1) |
|
So what have you learned? |
|
|
125 | (4) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
6 Clinical decision making |
|
|
129 | (20) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (2) |
|
The Mental Capacity Act 2010 |
|
|
133 | (2) |
|
|
135 | (3) |
|
The Human Rights Act 1998 |
|
|
138 | (1) |
|
The Data Protection Act 1998 |
|
|
139 | (1) |
|
|
140 | (3) |
|
Tips for safe practice in medicines management |
|
|
142 | (1) |
|
|
143 | (1) |
|
So what have you learned? |
|
|
144 | (5) |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
147 | (2) |
Answers to chapter questions |
|
149 | (4) |
Glossary |
|
153 | (4) |
Index |
|
157 | |